BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 32538593)

  • 1. Anticoagulation in Older Adults.
    Roth AR; Lazris A; Haskell H; James J
    Am Fam Physician; 2020 Jun; 101(12):748-750. PubMed ID: 32538593
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors Associated With the Choice of Oral Anticoagulant Class in the Older Patients: An Observational Study.
    Pagès A; Sabatier R; Sallerin B
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):332-337. PubMed ID: 32266832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Anticoagulants for Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Pilot Study.
    Chapin TW; Leedahl DD; Brown AB; Pasek AM; Sand MG; Loy ML; Dyke CM
    J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):523-530. PubMed ID: 32476465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients.
    Schäfer A; Flierl U; Berliner D; Bauersachs J
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):555-568. PubMed ID: 32350792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Edoxaban for the Prevention of Thromboembolism in Patients With Atrial Fibrillation and Bioprosthetic Valves.
    Carnicelli AP; De Caterina R; Halperin JL; Renda G; Ruff CT; Trevisan M; Nordio F; Mercuri MF; Antman E; Giugliano RP;
    Circulation; 2017 Mar; 135(13):1273-1275. PubMed ID: 28209729
    [No Abstract]   [Full Text] [Related]  

  • 7. Which oral anticoagulant for atrial fibrillation.
    Med Lett Drugs Ther; 2016 Apr; 58(1492):45-6. PubMed ID: 27049507
    [No Abstract]   [Full Text] [Related]  

  • 8. Nonvitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients and Risk of Dementia: A Nationwide Propensity-Weighted Cohort Study.
    Søgaard M; Skjøth F; Jensen M; Kjældgaard JN; Lip GYH; Larsen TB; Nielsen PB
    J Am Heart Assoc; 2019 Jun; 8(11):e011358. PubMed ID: 31138001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death rates and causes in anticoagulated atrial fibrillation patients: a population-based study.
    Denas G; Fedeli U; Gennaro N; Ferroni E; Corti MC; Pengo V
    J Cardiovasc Med (Hagerstown); 2020 Jun; 21(6):415-419. PubMed ID: 32355064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
    Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
    J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Net Clinical Benefit of Oral Anticoagulation Among Older Adults With Atrial Fibrillation.
    Shah SJ; Singer DE; Fang MC; Reynolds K; Go AS; Eckman MH
    Circ Cardiovasc Qual Outcomes; 2019 Nov; 12(11):e006212. PubMed ID: 31707823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
    Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
    Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial bleedings in patients on long-term anticoagulant treatment: Benefits from oral thrombin and factor Xa inhibitors in clinical practice.
    Łukasik M; Zawilska K; Undas A
    Neurol Neurochir Pol; 2015; 49(3):171-9. PubMed ID: 26048605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical appraisal of the AUGUSTUS trial.
    Gremmel T; Sulzgruber P; Niessner A
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):187-188. PubMed ID: 31265054
    [No Abstract]   [Full Text] [Related]  

  • 15. Age-Related Differences in the Clinical Characteristics and Treatment of Elderly Patients With Atrial Fibrillation in Japan - Insight From the ANAFIE (All Nippon AF In Elderly) Registry.
    Hiasa KI; Kaku H; Inoue H; Yamashita T; Akao M; Atarashi H; Koretsune Y; Okumura K; Shimizu W; Ikeda T; Toyoda K; Hirayama A; Yasaka M; Yamaguchi T; Teramukai S; Kimura T; Kaburagi J; Takita A; Tsutsui H
    Circ J; 2020 Feb; 84(3):388-396. PubMed ID: 31969518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation with warfarin or edoxaban: An in-depth analysis from the ENGAGE AF-TIMI 48 randomized trial.
    Nelson SE; Giugliano RP; Antman EM; Park JG; Norden AD; Rost NS; Silverman S; Singhal AB; Lanz HJ; Braunwald E; Ruff CT;
    J Clin Neurosci; 2021 Apr; 86():294-300. PubMed ID: 33446422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrointestinal Bleeding With Edoxaban Versus Warfarin: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis In Myocardial Infarction).
    Aisenberg J; Chatterjee-Murphy P; Friedman Flack K; Weitz JI; Ruff CT; Nordio F; Mercuri MF; Choi Y; Antman EM; Braunwald E; Giugliano RP
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e003998. PubMed ID: 29748353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female Sex as a Thromboembolic Risk Factor in the Era of Nonvitamin K Antagonist Oral Anticoagulants.
    Gallù M; Marrone G; Legramante JM; De Lorenzo A; Di Daniele N; Noce A
    Cardiovasc Ther; 2020; 2020():1743927. PubMed ID: 32684980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct oral Xa inhibitors versus warfarin in patients with cancer and atrial fibrillation: a meta-analysis.
    Casula M; Fortuni F; Fabris F; Leonardi S; Gnecchi M; Sanzo A; Greco A; Rordorf R
    J Cardiovasc Med (Hagerstown); 2020 Aug; 21(8):570-576. PubMed ID: 32628422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF-TIMI 48 Trial.
    Wang K; Li H; Kwong WJ; Antman EM; Ruff CT; Giugliano RP; Cohen DJ; Magnuson EA;
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.